ZNF280B
Zinc finger protein 280B
Also known as: 5'OY11.1, SUHW2, Z280B_HUMAN, ZNF279, ZNF632
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86YH2
- Gene
- ZNF280B
- Ensembl
- ENSG00000275004
- Chromosome
- 22
- Canonical length
- 543 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The protein encoded by this gene is a transcription factor that upregulates expression of MDM2, which negatively regulates p53 expression. This gene is highly expressed in prostate cancer cells, which leads to a reduction in p53 levels and an increase in growth of the cancer cells. Several transcript variants have been found for this gene, but only one of them is protein-coding. [provided by RefSeq, Jan 2015]
Canonical amino-acid sequenceUniProt
543 residues, UniProt reviewed canonical sequence.
>Q86YH2|ZNF280B
1 MEQSCEEEKE PEPQKNIQET KQVDDEDAEL IFVGVEHVNE DAELIFVGVT SNSKPVVSNI
61 LNRVTPGSWS RRKKYDHLRK DTARKLQPKS HETVTSEAVT VLPASQLESR STDSPIIIEP
121 LSKPDYRNSS PQVVPNNSSE LPSPLITFTD SLHHPVSTAL SVGGINESPR VSKQLSTFEV
181 NSINPKRAKL RDGIIEGNSS ASFPSDTFHT MNTQQSTPSN NVHTSLSHVQ NGAPFPAAFP
241 KDNIHFKPIN TNLDRANELA KTDILSLTSQ NKTFDPKKEN PIVLLSDFYY GQHKGEGQPE
301 QKTHTTFKCL SCVKVLKNVK FMNHVKHHLE FEKQRNDSWE NHTTCQHCHR QFPTPFQLQC
361 HIENVHTAQE PSTVCKICEL SFETDQVLLQ HMKDHHKPGE MPYVCQVCHY RSSVFADVET
421 HFRTCHENTK NLLCPFCLKI FKTATPYMCH YRGHWGKSAH QCSKCRLQFL TFKEKMEHKT
481 QCHQMFKKPK QLEGLPPETK VTIQVSLEPL QPGSVDVASI TVSTSDSEPS LPRSKSKISK
541 KSHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF280B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- testis: 13 nTPM
- hypothalamus: 3.2 nTPM
- retina: 3 nTPM
- cerebral cortex: 2.6 nTPM
- cerebellum: 2.5 nTPM
- basal ganglia: 1.8 nTPM
Single-cell type
- early spermatids: 33 nCPM
- other brain neurons: 25 nCPM
- late spermatids: 22 nCPM
- brain inhibitory neurons: 21 nCPM
- brain excitatory neurons: 20 nCPM
- early primary spermatocytes: 17 nCPM
Immune cell
- basophil: 11 nTPM
- non-classical monocyte: 4.9 nTPM
- NK-cell: 4.7 nTPM
- naive CD8 T-cell: 4.3 nTPM
- MAIT T-cell: 3.8 nTPM
- neutrophil: 3.7 nTPM
Brain region
- hypothalamus: 12 nTPM
- cerebral cortex: 9.8 nTPM
- midbrain: 9 nTPM
- basal ganglia: 8 nTPM
- pons: 8 nTPM
- white matter: 7.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.71
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 0.13
- DepMap mean gene effect
- 0.16
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF280B as an antibody target. Whether an autoantibody or antibody against ZNF280B could matter depends on whether native ZNF280B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF280B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF280B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...